Concepedia

Roy Vitkon

RV

4

Publications

218

Citations

4

H-Index

2020

Active since

Affiliations

Tel Aviv Sourasky Medical Center(Current)

Tel Aviv University

Roy Vitkon is an author at Tel Aviv Sourasky Medical Center specializing in epidemiology, clinical trials, and hematology.

ORCID

Top concepts

Publications per year

2020–2023

4

Publications

4

Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma

Chava Perry, Efrat Luttwak, R. Balaban et al. · Blood Advances · 2021 · 166 citations · Full text

Ixazomib-based regimens for relapsed/refractory multiple myeloma: are real-world data compatible with clinical trial outcomes? A multi-site Israeli registry study

Yaël C. Cohen, Hila Magen, Noa Lavi et al. · Annals of Hematology · 2020 · 23 citations

, , +8

Daratumumab in combination with proteasome inhibitors, rapidly decreases polyclonal immunoglobulins and increases infection risk among relapsed multiple myeloma patients: a single center retrospective study

Roy Vitkon, Dan Netanely, Shai Levi et al. · Therapeutic Advances in Hematology · 2021 · 19 citations · Full text

Vagal Nerve Activity Predicts Prognosis in Diffused Large B-Cell Lymphoma and Multiple Myeloma

Or Atar, Ron Ram, Irit Avivi et al. · Journal of Clinical Medicine · 2023 · 10 citations · Full text

Rows per page

1–4 of 4